Medicine Man Technologies, Inc. SHWZ
We take great care to ensure that the data presented and summarized in this overview for Medicine Man Technologies, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Latest Institutional Activity in SHWZ
Top Purchases
Top Sells
About SHWZ
Medicine Man Technologies, Inc., doing business as Schwazze, operates as a cannabis company. It operates through three segments: Retail, Wholesale, and Other. The company offers cannabis products that include loose flower, concentrates, edibles, pre-rolls, topicals, and other associated cannabis products; and vape cartridges and syringes. As of March 14, 2022, it owned and operated 23 retail cannabis dispensaries under the Star Buds, Smoking Gun Apothecary, Emerald Fields, and Drift banner names in Denver and Colorado; and 10 medical retail cannabis dispensaries under the R. Greenleaf banner in New Mexico. The company also provides licensing and consulting, facility design, and facility management services; and Three A Light publication. In addition, it manufactures, wholesales, and retails various plant nutrients for cannabis; and supplies hydroponics and indoor gardening supplies. The company was incorporated in 2014 and is headquartered in Denver, Colorado.
Insider Transactions at SHWZ
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 28
2024
|
Marc R Rubin Director |
BUY
Grant, award, or other acquisition
|
Direct |
67,308
+21.57%
|
-
|
|
Jun 28
2024
|
Brad Stewart Director |
BUY
Grant, award, or other acquisition
|
Direct |
72,436
+25.12%
|
-
|
|
Jun 28
2024
|
Kathy P Vrabeck Director |
BUY
Grant, award, or other acquisition
|
Direct |
67,308
+34.59%
|
-
|
|
Jun 28
2024
|
Jonathan W Berger Director |
BUY
Grant, award, or other acquisition
|
Direct |
139,103
+19.13%
|
-
|
|
Jun 28
2024
|
Jeffrey Alley Cozad Director |
BUY
Grant, award, or other acquisition
|
Direct |
70,513
+17.96%
|
-
|
|
Jun 28
2024
|
Justin Dye Director |
BUY
Grant, award, or other acquisition
|
Direct |
192,308
+8.68%
|
-
|
|
Jun 28
2024
|
Paul Joseph Montalbano Director |
BUY
Grant, award, or other acquisition
|
Direct |
67,308
+17.35%
|
-
|
|
Jun 28
2024
|
Pratap Chandra Mukharji Director |
BUY
Grant, award, or other acquisition
|
Direct |
67,308
+17.64%
|
-
|
|
May 03
2024
|
Christine Jones Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
13,653
+43.12%
|
-
|
|
May 03
2024
|
Daniel Pabon Chief Policy Officer |
BUY
Grant, award, or other acquisition
|
Direct |
15,170
+49.75%
|
-
|
|
May 03
2024
|
Forrest Hoffmaster Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
18,204
+29.64%
|
-
|
|
Apr 11
2024
|
Daniel Pabon Chief Policy Officer |
BUY
Open market or private purchase
|
Direct |
150
+50.0%
|
$0
$0.7 P/Share
|
|
Mar 29
2024
|
Brad Stewart Director |
BUY
Grant, award, or other acquisition
|
Direct |
34,451
+19.36%
|
-
|
|
Mar 29
2024
|
Justin Dye Director |
BUY
Grant, award, or other acquisition
|
Direct |
91,463
+4.76%
|
-
|
|
Mar 29
2024
|
Jonathan W Berger Director |
BUY
Grant, award, or other acquisition
|
Direct |
66,159
+12.85%
|
-
|
|
Mar 29
2024
|
Paul Joseph Montalbano Director |
BUY
Grant, award, or other acquisition
|
Direct |
32,012
+11.22%
|
-
|
|
Mar 29
2024
|
Kathy P Vrabeck Director |
BUY
Grant, award, or other acquisition
|
Direct |
32,012
+34.81%
|
-
|
|
Mar 29
2024
|
Pratap Chandra Mukharji Director |
BUY
Grant, award, or other acquisition
|
Direct |
32,012
+11.47%
|
-
|
|
Mar 29
2024
|
Jeffrey Alley Cozad Director |
BUY
Grant, award, or other acquisition
|
Direct |
33,537
+11.76%
|
-
|
|
Mar 29
2024
|
Marc R Rubin Director |
BUY
Grant, award, or other acquisition
|
Direct |
32,012
+15.28%
|
-
|
Last 12 Months Summary
| Grant, award, or other acquisition | 1.61M shares |
|---|---|
| Open market or private purchase | 61.3K shares |